At Vitalli Bio, we aim to modify the immune system to treat immunological disorders, and improve lives.
Ingenuity in Immunology.
Inspired by Patients’ Needs.
We’re building a company focused on modulating the immune system to help people break free of the burden of autoimmunity. Our mission is embodied in our name: Vitalli – helping people to “live life to the fullest.”
Meet the team translating scientific innovation into patient value.
An Urgent Call to Action in Autoimmune Diseases
The prevalence of autoimmune diseases continues to increase in the United States and around the world, impacting the lives of millions of patients and families, and straining an already over-burdened healthcare system. Vitalli Bio is answering the call for novel therapeutic approaches that will safely and effectively fill unmet treatment needs and elevate the standard-of-care for patients.
Explore our bold opportunities to change the patient journey in autoimmune diseases.
Dual Targets. One Goal.
A Robust and Balanced Immune Response.
Vitalli Bio aims to apply the promise of dual Interleukin-2-inducible T-cell Kinase (ITK) and Bruton’s tyrosine kinase (BTK) target inhibition to synergistically inhibit autoimmune disease pathways for the treatment of diseases.
Learn more about our lead investigational product candidate, VIT-801.